Pune: Serum Institute Stops Corona Vaccine Trial
Pune, September 10, 2020: A day after the Drugs Controller General of India (DCGI) issued show-cause notice to the city-based Serum Institute of India (SSI), the company has decided to pause the human trial of Coronavirus vaccine, COVISHIELD.
“We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI’s instructions and will not be able to comment further on trials. You can connect with DCGI for more updates on this front”, the company issued a statement.
London-based pharma company AstraZeneca, which is developing the Corona vaccine in collaboration with Oxford University, had to stop clinical trials. This decision had to be taken because a person involved in the trial got ill. The company gave this information on Tuesday and described it as routine action. They also said that the severity of the disease in the patient is not yet known.
About a month ago, the DCGI had given approval to Serum Institute of India (SII), Pune to conduct Phase II+III clinical trials of Oxford University-AstraZeneca COVID19 vaccine (COVISHIELD) in India.
